Body weight gain induced by antipsychotic drugs: mechanisms and management.
about
Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the MythsSpecial considerations in the treatment of patients with bipolar disorder and medical co-morbiditiesObesity in children with autism spectrum disorderAltered dopamine D2 receptor function and binding in obese OLETF ratIncentives and barriers to lifestyle interventions for people with severe mental illness: a narrative synthesis of quantitative, qualitative and mixed methods studies.Dopamine and binge eating behaviorsSecond generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.Obesity Prevention for Children with Developmental Disabilities.Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults.Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?Binge eating symptomatology in overweight and obese patients with schizophrenia: a case control studyAltered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status.Inhibition of ATP-sensitive potassium channels by haloperidol.Pharmacotherapy of first-episode psychosis.Eating and weight related cognitions in people with Schizophrenia : a case control studyPharmacotherapy to limit weight gain caused by antipsychotic use.Atypical antipsychotic weight gain: a major clinical challenge.The assessment and management of antipsychotic-associated metabolic disturbances from a psychiatric perspective.Neural correlates of taste and pleasantness evaluation in the metabolic syndromePsychological underpinnings of metabolic syndrome.Effects of auricular acupressure on body weight parameters in patients with chronic schizophrenia.Food reinforcement and eating: a multilevel analysis.A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.Evidence review and clinical guidance for the use of ziprasidone in Canada.Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven reviewDopamine-related frontostriatal abnormalities in obesity and binge-eating disorder: emerging evidence for developmental psychopathologyMesolimbic dopamine in obesity and diabetes.Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.Physical and mental factors associated with obesity in individuals with mental disorders attending psychiatric day-care facilitiesWeight gain in bipolar disorder: pharmacological treatment as a contributing factor.Prolactinoma-associated obesity treated with bupropion and methylphenidate.Youth, caregiver, and prescriber experiences of antipsychotic-related weight gain.Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity.The impact of weight gain associated with atypical antipsychotic use in schizophrenia.Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder.Antipsychotic drugs and obesity: is prolactin involved?Effects of weight loss diet therapy on anthropometric measurements and biochemical variables in schizophrenic patients.Psychiatric patient and anaesthesia.Carbohydrate reward and psychosis: an explanation for neuroleptic induced weight gain and path to improved mental health?
P2860
Q24596954-86EC9182-514C-4C88-917A-911670B28862Q24806762-F093C036-4802-420E-9AAF-8361CF22B95DQ26860363-75A8B18A-3ADD-43DF-9CD7-A9E0E463D7EDQ30491597-C6BC5D25-CB72-4E8C-854D-099B901E71F2Q33821289-A440E59C-7F60-4D32-95CC-DE5883C04B8BQ34296538-513F1953-EB22-4F62-AD5B-5D890D93B596Q34376884-789738EC-AB54-4F08-A9AF-939DC041B672Q34711543-D157FF75-973D-40C1-B9F8-DD123FD117B6Q34905903-0EC57A7E-3D67-4309-A37E-3A35B564BEF8Q34991293-C985EE43-C8CF-4F18-AE9D-07BBB2C90C4BQ35040070-8313B810-564F-4903-BD46-36DE6DB780B1Q35043538-74B8EE42-537E-4023-A760-079197C33F82Q35048471-B161C495-D409-44EE-B40D-0E3464D150DBQ35124708-F442C8C6-2CDB-4747-A89A-04DDF68D75DFQ35126654-027F83E6-22CF-49F7-B184-A89CC9EC19F0Q35548146-5583FF96-8150-4A87-BDBE-7AC71D1F4C3AQ35592513-7F10B820-562B-4A7D-B415-64657ADBB60AQ35752734-F7F262FF-CDC2-417A-8A6E-E25E0DDF5315Q36073371-AD55AEC9-7941-4113-A513-70CDBE6CF63FQ36209843-6FC9610F-75B0-4048-8B76-417B9B3514A7Q36241602-71340EBC-9945-4503-B238-072A771FC698Q36416603-FFB7201B-A348-4580-9891-A19C738D195EQ36573892-71398B06-E629-4C89-8C54-15383ACEA0B8Q36588607-FF1EF9D8-C043-4E5F-9557-553C8DDFB03CQ36600817-C41F70F2-1FD2-4371-92FF-8523BBBDDF53Q36786531-7D113D8E-99E5-419D-8BC5-EB398A0EE13EQ36862774-FC645863-CE39-44C3-93DE-B426E6B5CF15Q37047473-9E3E5945-93F3-4DF7-826A-CDC13A47D6BCQ37140779-30F89293-ADE6-4DD8-9074-22ADB63016CCQ37171035-E9E80B27-625F-48DC-9EFE-9FD6C03E4DA5Q37248113-A18B0BFE-B0F1-437F-9028-CC1AA8C3FAB3Q37515292-AE43D52B-CD44-4AE0-B65C-B888F133FE15Q37676725-BC4D3EF6-336D-4491-8046-C9A92C0DBA0FQ38737909-8DEAA917-D01B-420A-90DA-6E563999A453Q38777526-8DEE3F02-7502-4464-A0DB-B27DDEC29985Q40555955-33D957F6-0D9E-4A0C-B5E9-E667CCD21BE8Q40669926-CEF67D6E-8EA7-460E-AC17-BD6B412FBB1DQ41733975-6C519FFF-E82A-4AB4-A60B-5CF6605DB460Q41837990-C3F9B586-AD64-4D32-9A00-02C3974BCACCQ42790337-6E96FD42-E355-4D0A-ADE0-D190B50412CE
P2860
Body weight gain induced by antipsychotic drugs: mechanisms and management.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Body weight gain induced by antipsychotic drugs: mechanisms and management.
@ast
Body weight gain induced by antipsychotic drugs: mechanisms and management.
@en
type
label
Body weight gain induced by antipsychotic drugs: mechanisms and management.
@ast
Body weight gain induced by antipsychotic drugs: mechanisms and management.
@en
prefLabel
Body weight gain induced by antipsychotic drugs: mechanisms and management.
@ast
Body weight gain induced by antipsychotic drugs: mechanisms and management.
@en
P2860
P1476
Body weight gain induced by antipsychotic drugs: mechanisms and management.
@en
P2093
Baptista T
P2860
P356
10.1111/J.1600-0447.1999.TB10908.X
P407
P577
1999-07-01T00:00:00Z